Individualizing targets and tactics for high-risk patients with type 2 diabetes: practical lessons from ACCORD and other cardiovascular trials

Diabetes Care. 2012 Oct;35(10):2100-7. doi: 10.2337/dc12-0650.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Glucose / drug effects
  • Blood Glucose / metabolism
  • Cardiovascular Diseases / etiology*
  • Cardiovascular Diseases / prevention & control
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / mortality
  • Glycated Hemoglobin / drug effects
  • Humans
  • Insulin / administration & dosage
  • Middle Aged
  • Precision Medicine / methods*
  • Randomized Controlled Trials as Topic
  • Risk

Substances

  • Blood Glucose
  • Glycated Hemoglobin A
  • Insulin
  • hemoglobin A1c protein, human